drugset / Trial / NCT01183143
Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization
NaSingle-groupOpen-labelTreatment
Summary
This was a prospective, open-label, non-comparative, Phase IIIb trial to assess the convenience, safety and efficacy of the new Gonal-F fbm \[recombinant follicle stimulating hormone (r-FSH)\] liquid formulation, in common setting for ovulation induction (OI) and also in in-vitro fertilization (IVF).
Timeline
- Start
- 2004-05-11
- Primary completion
- 2006-03-02
- Completion
- 2006-03-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gonal-f | Protein / enzyme biologic | 75 iu | Subcutaneous |
| Subject | Gonal-f | Protein / enzyme biologic | 150 iu | Subcutaneous |
| Subject | Gonal-f | Protein / enzyme biologic | 225 iu | Subcutaneous |